The Drug Enforcement Administration (DEA) announced last Friday that certain Food and Drug Administration (FDA)-approved drugs that contain cannabidiol (CBD) are properly rescheduled as Schedule V drugs under the Controlled Substances Act (CSA). While this move is far from categorically rescheduling CBD – as only...
I. Background Recently, we reported on the current state of hemp and CBD laws in the United States following the Ninth Circuit’s April 2018 decision in HIA v. DEA (Case No. 17-70162), the proposed Hemp Farming Act of 2018 (S. 2667), and reading through to...
In our previous post, we discussed general rules applicable to the transportation of cannabis both across and within state lines. Here, we discuss the issue of who is responsible when an accident happens – or worse, an intentional wrongful act is committed – by an...
Some of the most commonly asked questions by cannabis business owners and operators, as well as consumers, involve the transportation of marijuana and the applicable laws, as well as the division of liability between the business owner and the driver. Transportation of marijuana is highly regulated....
By: Sam Mendez, Strategic Legal Counsel at Cultiva Law The Washington State Liquor and Cannabis Board (WSLCB) recently proposed a “Hidden Ownership Amnesty Program” at their June 27, 2018 Executive Management Team meeting. Insiders learned about this development after a transcript (see p. 5) was written up by a team...
An Analysis of Hemp Industries Association, et al. v. U.S. Drug Enforcement Administration (Case No. 17-70162) and the Hemp Farming Act of 2018 (S. 2667) I. Hemp Industries Ass’n. v. DEA (April 30, 2018) The Ninth Circuit Court of Appeals issued its decision in Hemp Industries Association,...